Academic History
Julien Taieb, MD, PhD, is Professor at Paris Descartes University, Paris, France, and head of the Gastroenterology and Gastrointestinal Oncology Department at the Georges Pompidou European Hospital, Paris, France. He received his undergraduate Bachelor’s degree, MD, and PhD from the Université Pierre et Marie Curie, Paris, France.
His current roles also include serving as a reviewer for various publications, such as The Lancet Oncology and the European Journal of Cancer. He is a member of the European Society for Medical Oncology (ESMO), where he also serves on the administrative council of the scientific committee and is the faculty coordinator for the ESMO Gastrointestinal Tumors Faculty. He is also a member of the American Society of Clinical Oncology (ASCO) and holds positions with multiple French gastrointestinal cooperatives and societies including the Fédération Francophone de Cancérologie Digestive (FFCD) and the Société Nationale Française de Gastro-Entérologie (SNFGE).
Speaking on precision oncology in colorectal cancer
Prof. Taieb’s research interests include gastroenterology, oncology, medical education, immunology, molecular biology, epidemiology, public health, and genetics. His main research topics are non-metastatic and metastatic colorectal cancer and pancreatic cancer. He has led more than 10 Phase III and 20 Phase I/II and has published multiple translational research articles from the findings. He advocates for improved standards of care for colon cancer patients through the identification of biomarkers to guide treatment, in particular, he has highlighted the value of circulating tumor DNA (ctDNA) as a marker for disease recurrence. His analysis of the PRODIGE-GERCOR IDEA-France trial found the ctDNA assessment was an independent prognostic marker.
Sorry, no posts matched your criteria.
